LEO Pharma
Manufacturing · Denmark · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Industriparken 55, Ballerup, Region Hove...Phone Number
+45 44945888Website
www.leo-pharma.comRevenue
$1.6 BillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
1
1
1
About LEO Pharma
Founded in 2008, LEO Pharma is a multinational Danish pharmaceutical company specializing in dermatology.Explore more
LEO Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LEO Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once LEO Pharma has new funding data
Click to see if LEO Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if LEO Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
LEO Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if LEO Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at LEO Pharma
Earning: See what the market has to say on LEO Pharma recently announced quarterly report
Product Launch: Get notified when LEO Pharma launches new products
Recommended Actions
Reach out to Masked Content who joined LEO Pharma as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
LEO Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LEO Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LEO Pharma.
LEO Pharma Tech Stack
A closer look at the technologies used by LEO Pharma
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Pharmaceuticals
Person-Based
Person-Based
LEO Pharma News & Media
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
Er-Kim and LEO Pharma A/S sign exclusive agreement to launch LOQTORZI® across Central and Eastern Europe, expanding access to innovative cancer treatmentLEO Pharma Announces Positive 16-Week Interim Results for ADHAND Trial for Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis on the Hands who are Candidates for Systemic Therapy
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma Announces Positive 16-Week Interim Results for ADHAND Trial for TralokinumabLEO Pharma Initiates Phase 2a DELTA NEXT Trial of Delgocitinib Cream in Adults with Mild to Severe Palmoplantar Pustulosis (PPP)
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma Initiates Phase 2a DELTA NEXT Trial of Delgocitinib Cream in Adults with Mild to Severe Palmoplantar Pustulosis (PPP)Three-month interim report (Q1) 2025 (Unaudited): LEO Pharma Delivers 9% Revenue Growth at Constant Exchange Rates and Doubles Adjusted EBITDA Margin to 16%
BALLERUP, Denmark--(BUSINESS WIRE)--Q1 2025 (Unaudited): LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16%
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LEO Pharma
Sign Up For FreeTo access detailed company insights
Founded in 2008, LEO Pharma is a multinational Danish pharmaceutical company specializing in dermatology.... Read More
